Abstract
Motor symptoms that define Parkinson's disease (PD) are caused by the selective loss of nigral dopaminergic (DA) neurons. Cell replacement therapy for PD has been focused on midbrain DA neurons derived from human fetal mesencephalic tissue, human embryonic stem cells (hESC) or human induced pluripotent stem cells (iPSC). Recent development in the direct conversion of human fibroblasts to induced dopaminergic (iDA) neurons offers new opportunities for transplantation study and disease modeling in PD. The iDA neurons are generated directly from human fibroblasts in a short period of time, bypassing lengthy differentiation process from human pluripotent stem cells and the concern for potentially tumorigenic mitotic cells. They exhibit functional dopaminergic neurotransmission and relieve locomotor symptoms in animal models of Parkinson's disease. In this review, we will discuss this recent development and its implications to Parkinson's disease research and therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 606-612 |
| Number of pages | 7 |
| Journal | Redox Biology |
| Volume | 11 |
| DOIs | |
| State | Published - Apr 1 2017 |
Keywords
- Induced dopaminergic neuron
- Induced neuron
- Induced pluripotent stem cell
- Parkinson's disease
- Transcription factor
Fingerprint
Dive into the research topics of 'Induced dopaminergic neurons: A new promise for Parkinson's disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver